Free press releases distribution network?

Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Quotient Bioresearch Invests in Next Generation Thermo Fisher Scientific Mass Spectrometry Equipment - Quotient Bioresearch invests in next generation Thermo Fisher Scientific Mass Spectrometry equipment for Metabolite identification
Quotient Bioresearch Invests in Next Generation Thermo Fisher Scientific Mass Spectrometry Equipment

 

PRZOOM - /newswire/ - Cambridge, United Kingdom, 2008/11/09 - Quotient Bioresearch invests in next generation Thermo Fisher Scientific Mass Spectrometry equipment for Metabolite identification.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Quotient Bioresearch, a leading provider of early phase drug development and sports testing services, today announces that it is investing in its development with the purchase of three Thermo Scientific LTQ Orbitrap™ XL mass spectrometers. This significant investment demonstrates Quotient Bioresearch’s commitment to offering the highest quality service to its customers.

The Thermo Scientific instrumentation will enable Quotient Bioresearch to offer its customers enhanced benefits in mass spectrometry and confirm its position as a leader in drug development and sports testing services. FDA guidance is increasingly driving the need to identify and quantitate key metabolites at the early stage of the drug development process. In recognition of this guidance, Quotient Bioresearch is investing in improved metabolite profiling technology, better coordination of human AME studies, through its radio synthesis group, and an enhanced metabolite identification capability. The decision to invest in three LTQ Orbitrap™ XL mass spectrometers is a key part of Quotient Bioresearch’s drive to develop its metabolite identification services.

Paul Cowan CEO and Chairman of the Quotient Group commented “We are very excited by the potential for the LTQ Orbitrap XL instruments to continue to develop Quotient Bioresearch’s position as a leader in metabolic sciences, an area of growing importance to the industry as it focuses on improving development efficiency.”

The LTQ Orbitrap™ XL offers unparalleled sensitivity and significant advancement in qualitative mass spectrometry by combining superior mass resolution with reliable high sensitivity MS/MSn performance. These capabilities support small molecule metabolite profiling and identification studies and offer a number of significant benefits such as speed, efficiency and flexibility; allowing accurate mass data on drugs and metabolites to be produced in almost half the time. In addition, the LTQ Orbitrap™ also offers exciting opportunities to extract metabolite information out of early toxicology and clinical research samples.

On behalf of Thermo Fisher Scientific, Steve Vaughan, UK general manager for scientific instruments commented, “We are delighted to have the opportunity to supply the three LTQ Orbitraps to Quotient Bioresearch. The reputation of both the sports testing and drug development sites of Quotient’s business are internationally renowned, and we look forward to forming a long lasting business partnership which will help them maximize the benefit of their investment with us.”

Press Contacts:
For more information on Quotient Bioresearch, please contact:
Emma Sutherland, Communications Executive
T: +44 (0) 1638 724203
E: info[.]quotientbioresearch.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: The Scott Partnership

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Quotient Bioresearch Invests in Next Generation Thermo Fisher Scientific Mass Spectrometry Equipment

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Laura Browne 
+44 1477 539539 thermouk[.]scottpr.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From The Scott Partnership / Company Profile


Read Medical Services/Equipment Most Recent Related Press Releases:

Agfa Specialty Products Announces the Launch of UNIQOAT
Sparta Releases Stratas 3.0 and TrackWise Intake
GE Healthcare Signs Agreement with HealthTrust to Supply Radiopharmaceuticals
GE Introduces CardioGraphe - The World’s First Dedicated Cardiovascular CT System
Frost & Sullivan Lauds ClearFlow’s ACT® Technology as a Transformational Force in Post-operative Cardiothoracic Surgery Protocols
ZOLL Receives Health Canada Approval for Two New Models of AEDS
ZOLL Hospital Wearable Defibrillator Receives Premarket Approval from the FDA
AFC Industries Joins HIMSS for its 56th Edition
Medical Companies Flock to Israel for R&D Support Infrastructure and Inorganic Growth Opportunities Finds Frost & Sullivan
GE Healthcare Expands MRI Contrast Media Product Range in Europe with Launch of Macrocyclic Agent Clariscan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  MagLar, Inc.

Visit  BizJobs.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today